The challenge of chronic insomnia: Is non-nightly hypnotic treatment a feasible alternative?

European Psychiatry

Volumn 18, Issue 5, 2003, Pages 201-208

  Hajak, G ^d   Cluydts, R ^e   Allain, H ^a   Estivill, E ^b   Parrino, L ^e   Terzano, M G ^e   Walsh, J K ^c  

^a RENNES UNIVERSITY HOSPITAL   (France)

^b INSTITUT UNIVERSITARI DEXEUS   (Spain)

^c ST LUKE S HOSPITAL   (United States)

^d UNIVERSITY OF REGENSBURG   (Germany)

^e NONE

Author keywords

Chronic insomnia; Hypnotic medication; Pharmacological treatment; Zolpidem

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; HYPNOTIC AGENT; ZOLPIDEM;

BEHAVIOR THERAPY; CHRONIC DISEASE; CLINICAL TRIAL; COST OF ILLNESS; DEPRESSION; DRUG SAFETY; HUMAN; INSOMNIA; LATENT PERIOD; LONG TERM CARE; PATIENT ATTITUDE; PATIENT SATISFACTION; POLYSOMNOGRAPHY; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SIDE EFFECT; SLEEP TIME; TIME SERIES ANALYSIS; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0041972287     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-9338(03)00089-0     Document Type: Review

References (57)

1. World Health Organization - Division of Mental Health and Prevention of Substance Abuse. Insomnia - an international Consensus Conference Report. Versailles, 13-15 October 1996. World Health Organization; 1998.
2. National Center on Sleep Disorders Research, National Heart, Lung and Blood Institute, National Institutes of Health. Insomnia: assessment and management in primary care. Sleep 1999;22(Suppl 2): S402-8.
3. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington (DC): American Psychiatric Association; 1994.
4. World Health Organization. International Classification of Diseases, tenth revision, chapter V (F): Mental and Behavioural Disorders (excluding disorders of psychological development). Clinical descriptions and guidelines. Geneva: World Health Organization; 1992.
5. Hajak G. Insomnia in primary care. Sleep 2000;23(Suppl 3):S54-63.
6. Üstün T, Privett M, Lecrubier Y, Weiller E, Simon G, Korten A, et al. Form, frequency and burden of sleep problems in general health care. Eur J Psychiatry 1996;11 (Suppl 1):5S-10S.
7. Hohagen F, Rink K, Kappler C, Schramm E, Riemann D, Weyerer S, et al. Prevalence and treatment of insomnia in general practice. A longitudinal study. Eur Arch Psychiatry Clin Neurosci 1993;242(6): 329-36.
8. Ganguli M, Reynolds CF, Gilby JE. Prevalence and persistence of sleep complaints in a rural older community sample: the MoVIES project. J Am Geriatr Soc 1996;44(7):778-84.
9. Katz DA, McHomey CA. Clinical correlates of insomnia in patients with chronic illness. Arch Intem Med 1998;158(10):1099-107.
10. Roth T, Ancoli-Israel S. Daytime consequences and correlates of insomnia in the United States: results of the 1991 National Sleep Foundation Survey. II. Sleep 1999;22(Suppl 2):S354-8.
11. Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? JAMA 1989;262(11):1479-84.
12. Stoller MK. Economic effects of insomnia. Clin Ther 1994;16(5): 873-97.
13. Gillin JC. Are sleep disturbances risk factors for anxiety, depressive and addictive disorders? Acta Psychiatr Scand Suppl 1998;393:39-43.
14. Jenkins CD, Stanton BA, Niemcryk SJ, Rose RM. A scale for the estimation of sleep problems in clinical research. J Clin Epidemiol 1988;41(4):313-21.
15. Carney RM, Freedland KE, Jaffe AS. Insomnia and depression prior to myocardial infarction. Psychosom Med 1990;52(6):603-9.
16. Bonnet MH, Arand DL. Heart rate variability in insomniacs and matched normal sleepers. Psychosom Med 1998;60(5):610-5.
17. Cole SR, Kawachi I, Sesso HD, Paffenbarger RS, Lee IM. Sense of exhaustion and coronary heart disease among college alumni. Am J Cardiol 1999;84(12):1401-5.
18. Schwartz S, McDowell Anderson W, Cole SR, Comoni-Huntley J, Hays JC, Blazer D. Insomnia and heart disease: a review of epidemiologic studies. J Psychosom Res 1999;47(4):313-33.
19. Ferini-Strambi L, Bianchi A, Zucconi M, Oldani A, Catronovo V, Smirne S. The impact of cyclic alternating pattern on heart rate variability during sleep in healthy young adults. Clin Neurophysiol 2000;111(1):99-101.
20. Ferri R, Parrino L, Smerieri A, Terzano MG, Elia M, Musumeci SA, et al. Cyclic alternating pattern and spectral analysis of heart rate variability during normal sleep. J Sleep Res 2000;9(1):13-8.
21. Costa E, Silva JA, Chase M, Sartorius N, Roth T. Special report from a symposium held by the World Health Organization and the World Federation of Sleep Research Societies: an overview of insomnias and related disorders - recognition, epidemiology, and rational management. Sleep 1996;19(5):412-6.
22. Ohayon MM. Prevalence of DSM-IV diagnostic criteria of insomnia: distinguishing insomnia related to mental disorders from sleep disorders. J Psychiatr Res 1997;31(3):333-46.
23. Ancoli-Israel S, Roth T. Characteristics of insomnia in the United States: results of the 1991 National Sleep Foundation Survey I. Sleep 1999;22(Suppl 2):S347-53.
24. Leger D, Guilleminault C, Dreyfus JP, Delahaye C, Paillard M. Prevalence of insomnia in a survey of 12,778 adults in France. J Sleep Res 2000;9(1):35-42.
25. Shochat T, Umphress J, Israel AG, Ancoli-Israel S. Insomnia in primary care patients. Sleep 1999;22(Suppl 2):S359-65.
26. Simon GE, VonKorff M. Prevalence, burden and treatment of insomnia in primary care. Am J Psychiatry 1997;154(10):1417-23.
27. Walsh JK, Engelhardt CL. The direct costs of insomnia in the United States for 1995. Sleep 1999;22(Suppl 2):S386-93.
28. Leger D, Levy E, Paillard M. The direct costs of insomnia in France. Sleep 1999;22(Suppl 2):S394-401.
29. Nino-Murcia G. Diagnosis and treatment of insomnia and risks associated with lack of treatment. J Clin Psychiatry 1992;53(Suppl):43-7.
30. Simen S, Hajak G, Schlaf G, Westenhofer J, Rodenbeck A, Bandelow B, et al. Chronic sleep complaints. Results of a representative survey in Germany. Nervenarzt 1995;66:686-95.
31. Kageyama T, Kabuto M, Nitta H, Kurokawa Y, Taira K, Suzuki S, et al. Prevalence of use of medically prescribed hypnotics among adult Japanese women in urban residential areas. Psychiatry Clin Neurosci 1998;52(1):69-74.
32. Everitt DE, Avorn J, Baker MW. Clinical decision-making in the evaluation and treatment of insomnia. Am J Med 1990;89(3):357-62.
33. Terzano MG, Parrino L, Spaggiari MC. The cyclic alternating pattern sequences in the dynamic organization of sleep. Electroenceph Clin Neurophysiol 1988;69:437-47.
34. Scharf MB, Stover R, McDannold M, Kaye H, Berkowitz DV. Comparative effects of sleep on a standard mattress to an experimental foam surface on sleep architecture and CAP rates. Sleep 1997;20: 1197-2000.
35. Terzano MG, Parrino L. Evaluation of EEG cyclic alternating pattern during sleep in insomniacs and controls under placebo and acute treatment with zolpidem. Sleep 1992;15:64-70.
36. Terzano MG, Parrino L, Boselli M, Spaggiari MC, Di Giovanni G, Smerieri A. Sensitivity of cyclic alternating pattern to prolonged pharmacotherapy: a 5-week study evaluating zolpidem in insomniac patients. Clin Neuropharmacol 1997;20:447-54.
37. American Sleep Disorders Association. Practice parameters for the indications for polysomnography and related procedures. Polysomnography Task Force, American Sleep Disorders Association Standards of Practice Committee. Sleep 1997;20(6):406-22.
38. Ohayon MM, Caulet M, Arbus L, Billard M, Coquerel A, Guieu JD, et al. Are prescribed medications effective in the treatment of insomnia complaints? J Psychosom Res 1999;47(4):359-68.
39. Walsh JK, Schweitzer PK. Ten-year trends in the pharmacological treatment of insomnia. Sleep 1999;22(3):371-5.
40. National Sleep Foundation. Omnibus Sleep in America Poll. 2000.
41. Mellinger GD, Balter MB, Uhlenhuth EH. Insomnia and its treatment. Prevalence and correlates Arch Gen Psychiatry 1985;42(3):225-32.
42. Balter MB, Uhlenhuth EH. New epidemiologic findings about insomnia and its treatment. J Clin Psychiatry 1992;53(Suppl 12):34-9.
43. Roehrs T, Pedrosi B, Rosenthal L, Roth T. Hypnotic self-administration and dose-escalation. Psychopharmacology (Berl) 1996;127(2):150-4.
44. Roth T New trends in insomnia management. J Psychopharmacol 1999;13(4 Suppl 1):S37-40.
45. Kripke DF, Chronic hypnotic use: the neglected problem. In: Koella WP, Ruther E, Schulz H, editors. Sleep '84. Stuttgart: Gustav Fischer Verlag; 1985. p. 338-40.
46. Gustafson R. Treating insomnia with a self-administered muscle relaxation training program: a follow-up. Psychol Rep 1992;70(1): 124-6.
47. Morin CM, Hauri PJ, Espie CA, Spielman AJ, Buysse DJ, Bootzin RR. Nonpharmacological treatment of chronic insomnia. An American Academy of Sleep Medicine review. Sleep 1999;22(8): 1134-56.
48. Hryshko-Mullen AS. Behavioral treatment of insomnia: the Wilford Hall Insomnia Program. Mil Med 2000;165(3):200-7.
49. Cluydts R, Peeters K, de Bouyalski I, Lavoisy J. Comparison of continuous versus intermittent administration of zolpidem in chronic insomniacs: a double-blind, randomized pilot study. J Int Med Res 1998;26(1):13-24.
50. Hajak G, Cluydts R, Declerck A, Estivill E, Middleton A, Sonka K, et al. Continuous versus non-nightly use of zolpidem in chronic insomnia: results of a large-scale, double-blind, randomized, out-patient study. Int Clin Psychopharmacology 2002;17:9-17.
51. Allain H,Arbus L, Schück S, and the Zolpidem Study Group. Efficacy and safety of zolpidem administered "as needed" in primary insomnia. Results of a double-blind, placebo-controlled study. Clin Drug Invest 2001;21(6):391-400.
52. Walsh JK, Roth T, Randazzo A, Erman M, Jamieson A, Scharf M, et al. Eight weeks of non-nightly use of zolpidem for primary insomnia. Sleep 2000;23(8):1087-96.
53. Cluydts R, Heyde K, De Volder I. Polysomnographic findings during non-continuous administration of zolpidem. Sleep Medicine Reviews 2002;6(Suppl 1):S13-21.
54. Hajak G, Bandelow B, Zulley J, Pittrow D. "As needed" pharmacotherapy combined with stimulus control treatment in chronic insomnia - assessment of a novel intervention strategy in a primary care setting. Ann Clin Psychiatry 2002;14:1-7.
55. Ohayon MM, Caulet M, Guilleminault C. How a general population perceives its sleep and how this relates to the complaint of insomnia. Sleep 1997;20:715-23.
56. Ohayon MM, Caulet M, Priest RG, Guilleminault C. DSM-IV and ICSD-90 insomnia symptoms and sleep dissatisfaction. Br J Psychiatry 1997;171:382-8.
57. Ohayon MM, Zulley J. Correlates of global sleep dissatisfaction in the German population. Sleep 2001;24:780-7.